Drawing for TRUCAD

USPTO serial 90570597

TRUCAD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
HARDY LUDLOW, TARAH KIM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TRUCAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ron N. Dreben

Ron N. Dreben MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541

Goods and services

ClassDescriptionStatusFirst use
010Medical diagnostic blood testing apparatus for use in the field of coronary artery disease; Medical test kits in the field of coronary artery disease consisting primarily of a blood collection tube containing a preservative, a set of reagents for purifying RNA, a set of primers and probes for quantifying transcript levels, and related computer software featuring an algorithm for computing risk of coronary artery disease sold as a unit for home use and for use by medical practitioners in the diagnosis of Atherosclerotic burden; medical devices for diagnosing coronary artery diseaseACTIVE
042Research services in the field of medicine, namely, scientific research services and medical researchACTIVE
044Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, Atherosclerotic load risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing guidance for hypercholesterolemia treatment; medical analysis for the treatment of coronary artery disease (CAD); healthcareACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 7, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 7, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 25, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2024EX5GSOU EXTENSION 5 GRANTED
Jun 25, 2024EXT5SOU EXTENSION 5 FILED
Jun 25, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 18, 2023EX4GSOU EXTENSION 4 GRANTED
Dec 18, 2023EXT4SOU EXTENSION 4 FILED
Dec 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 30, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2023EX3GSOU EXTENSION 3 GRANTED
Jun 28, 2023EXT3SOU EXTENSION 3 FILED
Jun 28, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 2, 2023EX2GSOU EXTENSION 2 GRANTED
Jan 2, 2023EXT2SOU EXTENSION 2 FILED
Jan 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2022EX1GSOU EXTENSION 1 GRANTED
Jul 2, 2022EXT1SOU EXTENSION 1 FILED
Jul 2, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 1, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 1, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 4, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2021DOCKASSIGNED TO EXAMINER
Jun 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2021NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance